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Mechanisms of immune tolerance can also be co-opted by
tumors to subvert anti-tumor effector T cell responses.
The lung represents a unique anatomic tissue of pro-
nounced immune tolerance where T lymphocytes do not
mount effector responses under steady state conditions
despite continual exposure to innocuous foreign antigens.
We hypothesized that a cell intrinsic mechanism by which
T lymphocyte behavior is modulated to promote local
immune suppression within the lungs can be inhibited to
promote anti-tumor T effector responses. Here, we
demonstrate that the family of prolyl-hydroxylase (Phd)
proteins promote T cell tolerance in the lung and limit
anti-tumor T cell responses throughout the body. Prolyl-
hydroxylase isoforms 1, 2, and 3 functioned redundantly
as oxygen sensors in T lymphocytes and enabled environ-
mental oxygen to limit effector differentiation in vitro and
in vivo. Mice with a T-cell specific deletion of all three
Phd proteins (Phd-tKO) developed spontaneous Th1-
mediated immunopathology in the lungs. Phd-tKO CD4+
T lymphocytes activated under normoxic conditions or
wild-type T cells activated under oxygen-deprivation con-
ditions exhibited reduced specification into T regulatory
cells (Treg) and instead defaulted to a Th1 program as
revealed by whole transcriptome RNA-sequence profiling
and induction of Tbet and IFNg protein expression. This
predisposition to effector cell specification in the absence
of Phd protein expression or under oxygen deprivation
was dependent on the functional expression of the hypoxia
inducible proteins HIF1a and HIF2a. Importantly, genetic
or pharmacologic inhibition of the Phd proteins in tumor
antigen-specific CD4+ T cells promoted anti-tumor effi-
cacy in murine models of adoptive cell transfer immu-
notherapy as indicated by increased tumor clearance and
improved overall survival of tumor-bearing mice. These
findings establish the oxygen sensing Phd proteins as a
T cell intrinsic regulatory node in immune homeostasis
that may be targeted genetically or pharmacologically to
promote anti-tumor immune responses.
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